{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:46:11Z","timestamp":1791963971878,"version":"4.3.4"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    The pathognomonic genetic alteration in Burkitt lymphoma (BL) is the immunoglobulin (\n                    <jats:italic toggle=\"yes\">IG<\/jats:italic>\n                    )-\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    translocation, causing intense nuclear MYC expression in almost all cases. Rare cases harbor\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    rearrangements yet lack detectable MYC protein expression. In this study, we report 8 cases of MYC protein\u2013negative sporadic BL (MYC\u207b sBL). These cases accounted for 1.4% (8\/574) of all sporadic BL cases. The median age was 10 years (range: 5 to 77\u00a0y), with a male-to-female ratio of 3:1. The majority (62.5%, 5\/8) presented with advanced-stage disease (III\/IV), and 25.0% (2\/8) had bone marrow involvement. Morphologically, all cases met the World Health Organization (WHO) diagnostic criteria for BL, characterized by monotonous medium-sized cells with a typical \u201cstarry sky\u201d pattern. Immunophenotypically, all cases exhibited a germinal center B-cell phenotype with nearly 100% Ki-67 positivity. Notably, MUM1 was positive in 50.0% (4\/8) of cases, while Epstein-Barr virus (EBV)-encoded RNA (EBER) was positive in only 25.0% (2\/8). Despite fluorescence in situ hybridization (FISH)-confirmed\n                    <jats:italic toggle=\"yes\">MYC<\/jats:italic>\n                    rearrangement and the absence of\n                    <jats:italic toggle=\"yes\">BCL2<\/jats:italic>\n                    or\n                    <jats:italic toggle=\"yes\">BCL6<\/jats:italic>\n                    abnormalities, MYC protein expression was undetectable. Furthermore, patients with MYC\u207b sBL exhibited significantly inferior overall survival (OS) compared with those with MYC protein\u2013positive sporadic BL (MYC\n                    <jats:sup>+<\/jats:sup>\n                    sBL) (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.0001, HR=404.1). These findings confirm that MYC\u207b sBL is a rare but distinct clinicopathological entity associated with poor clinical outcomes, despite lacking unique histologic features. The molecular mechanisms underlying the absence of MYC protein expression remain to be investigated.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002593","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T08:01:13Z","timestamp":1785484873000},"page":"1316-1323","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Sporadic Burkitt Lymphoma Lacking MYC Protein Expression"],"prefix":"10.1097","volume":"50","author":[{"given":"Xiaoying","family":"Lou","sequence":"first","affiliation":[{"name":"Department of Pathology, The Sixth Affiliated Hospital of Sun Yat-sen University"},{"name":"Guangzhou (Huangpu) Zhongliu Biomedical Innovation Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqi","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine"},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine"},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Lei","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second People\u2019s Hospital of Foshan, Foshan, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine"},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine"},{"name":"Department of Pathology, Sun Yat-sen University Cancer Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"R1-20261014","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1038\/sj.onc.1204595","article-title":"Translocations involving c-myc and c-myc function","volume":"20","author":"Boxer","year":"2001","journal-title":"Oncogene"},{"key":"R2-20261014","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-022-00404-3","article-title":"Burkitt lymphoma","volume":"8","author":"L\u00f3pez","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20261014","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00428-022-03404-6","article-title":"Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B\u2011cell lymphoma","volume":"482","author":"King","year":"2023","journal-title":"Virchows Arch"},{"key":"R4-20261014","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/s41467-019-08578-3","article-title":"Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma","volume":"10","author":"L\u00f3pez","year":"2019","journal-title":"Nat Commun"},{"key":"R5-20261014","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2559.2011.03978.x","article-title":"Immunohistochemical detection of MYC protein correlates with MYC gene status in aggressive B cell lymphomas","volume":"59","author":"Tapia","year":"2011","journal-title":"Histopathology"},{"key":"R6-20261014","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41408-019-0252-2","article-title":"Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases","volume":"9","author":"Mundo","year":"2019","journal-title":"Blood Cancer J"},{"key":"R7-20261014","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.3324\/haematol.2018.208140","article-title":"Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of \u201cMYC-negative\u201d Burkitt lymphoma","volume":"105","author":"Wagener","year":"2020","journal-title":"Haematologica"},{"key":"R8-20261014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hon.916","article-title":"Burkitt lymphoma versus diffuse large B-cell lymphoma: a practical approach","volume":"28","author":"Bellan","year":"2010","journal-title":"Hematol Oncol"},{"key":"R9-20261014","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/ajcp\/aqv010","article-title":"Extranodal natural killer\/T-cell lymphoma in children and adolescents: a report of 17 cases in China","volume":"145","author":"Huang","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"R10-20261014","doi-asserted-by":"crossref","first-page":"100441","DOI":"10.1016\/j.modpat.2024.100441","volume":"37","author":"Medeiros","year":"2024","journal-title":"Mod Pathol"},{"key":"R11-20261014","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/PAS.0000000000000365","article-title":"Expression profiles of MYC protein and MYC gene rearrangement in lymphomas","volume":"39","author":"Chisholm","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R12-20261014","first-page":"3994","article-title":"Deciphering discordance between MYC mRNA and MYC IHC in DLBCL: the role of MYC exon 2 mutations and N11S polymorphism","volume":"130","author":"Collinge","year":"2017","journal-title":"Blood"},{"key":"R13-20261014","doi-asserted-by":"crossref","first-page":"e0263980","DOI":"10.1371\/journal.pone.0263980","article-title":"Cryptic MYC insertions in Burkitt lymphoma: new data and a review of the literature","volume":"17","author":"Woroniecka","year":"2022","journal-title":"PLoS One"},{"key":"R14-20261014","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12308-008-0017-5","article-title":"Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach","volume":"1","author":"Rijk","year":"2008","journal-title":"J Hematop"},{"key":"R15-20261014","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1186\/s12885-015-1661-7","article-title":"Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation","volume":"15","author":"Falco","year":"2015","journal-title":"BMC Cancer"},{"key":"R16-20261014","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/leu.2011.156","article-title":"The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma","volume":"25","author":"Lenze","year":"2011","journal-title":"Leukemia"},{"key":"R17-20261014","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1182\/blood-2008-07-170589","article-title":"MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1","volume":"113","author":"Garzon","year":"2009","journal-title":"Blood"},{"key":"R18-20261014","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1038\/sj.emboj.7600217","article-title":"Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7","volume":"23","author":"Yada","year":"2004","journal-title":"EMBO J"},{"key":"R19-20261014","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S1097-2765(03)00173-4","article-title":"Skp2 regulates Myc protein stability and activity","volume":"11","author":"Kim","year":"2003","journal-title":"Mol Cell"},{"key":"R20-20261014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/PAP.0b013e3182169948","article-title":"MYC and aggressive B-cell lymphomas","volume":"18","author":"Slack","year":"2011","journal-title":"Adv Anat Pathol"},{"key":"R21-20261014","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/cancers10110448","article-title":"Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition","volume":"10","author":"Poole","year":"2018","journal-title":"Cancers (Basel)"},{"key":"R22-20261014","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ajcp\/aqae158","article-title":"How I diagnose high-grade B-cell lymphoma","volume":"163","author":"Moore","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"R23-20261014","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/blood.2020008374","article-title":"Defining and treating high-grade B-cell lymphoma, NOS","volume":"140","author":"Olszewski","year":"2022","journal-title":"Blood"},{"key":"R24-20261014","first-page":"499","article-title":"Current treatment of Burkitt lymphoma and high-grade B-cell lymphomas","volume":"36","author":"Johnson","year":"2022","journal-title":"Oncology (Williston Park)"},{"key":"R25-20261014","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.humpath.2023.03.013","article-title":"High-grade B-cell lymphoma with concurrent MYC rearrangement and 11q aberrations: clinicopathologic, cytogenetic, and molecular characterization of 4 cases","volume":"136","author":"Shestakova","year":"2023","journal-title":"Hum Pathol"},{"key":"R26-20261014","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.humpath.2023.07.008","article-title":"Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma","volume":"139","author":"Sung","year":"2023","journal-title":"Hum Pathol"},{"key":"R27-20261014","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/EQJR3D3V0CCQGP04","article-title":"Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH","volume":"128","author":"Chuang","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"R28-20261014","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3960\/jslrt.23007","article-title":"High-grade B-cell lymphoma with 11q aberrations: a single-center study","volume":"63","author":"Yamada","year":"2023","journal-title":"J Clin Exp Hematop"},{"key":"R29-20261014","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"199","author":"Wagener","year":"2019","journal-title":"Blood"},{"key":"R30-20261014","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Farre","year":"2019","journal-title":"Haematologica"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:00:21Z","timestamp":1791961221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002593"}},"subtitle":["A Rare Entity With Diagnostic Pitfalls and Dismal Prognosis"],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002593","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}